These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38815672)

  • 1. Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
    Pisklova M; Osmak G
    Int J Cardiol; 2024 Sep; 410():132220. PubMed ID: 38815672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-Regulated Pathways for Hypertrophic Cardiomyopathy: Network-Based Approach to Insight into Pathogenesis.
    Osmak G; Baulina N; Kiselev I; Favorova O
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art.
    Angelopoulos A; Oikonomou E; Vogiatzi G; Antonopoulos A; Tsalamandris S; Georgakopoulos C; Papanikolaou P; Lazaros G; Charalambous G; Siasos G; Vlachopoulos C; Tousoulis D
    Curr Med Chem; 2021; 28(36):7400-7412. PubMed ID: 33820510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.
    Guo L; Cai Y; Wang B; Zhang F; Zhao H; Liu L; Tao L
    Eur J Med Res; 2023 Jun; 28(1):205. PubMed ID: 37391825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.
    Thottakara T; Lund N; Krämer E; Kirchhof P; Carrier L; Patten M
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.
    Liu S; Yuan P; Zheng Y; Guo C; Ren Y; Weng S; Zhang Y; Liu L; Xing Z; Wang L; Han X
    ESC Heart Fail; 2024 Aug; 11(4):2234-2248. PubMed ID: 38629342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis.
    Tang X; Shen Y; Lu Y; He W; Nie Y; Fang X; Cai J; Si X; Zhu Y
    Medicine (Baltimore); 2024 Jan; 103(4):e36799. PubMed ID: 38277535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers.
    Dai H; Liu Y; Zhu M; Tao S; Hu C; Luo P; Jiang A; Zhang G
    J Cell Mol Med; 2024 Aug; 28(16):e70034. PubMed ID: 39160643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.
    Liang LW; Hasegawa K; Maurer MS; Reilly MP; Fifer MA; Shimada YJ
    Circ Heart Fail; 2023 Jun; 16(6):e010010. PubMed ID: 37305994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic identification and analysis of dysregulated miRNA and transcription factor feed-forward loops in hypertrophic cardiomyopathy.
    Shi H; Li J; Song Q; Cheng L; Sun H; Fan W; Li J; Wang Z; Zhang G
    J Cell Mol Med; 2019 Jan; 23(1):306-316. PubMed ID: 30338905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrophic Cardiomyopathy as an Oligogenic Disease: Transcriptomic Arguments].
    Baulina NM; Kiselev IS; Chumakova OS; Favorova OO
    Mol Biol (Mosk); 2020; 54(6):955-967. PubMed ID: 33276358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA profiles in cats with hypertrophic cardiomyopathy.
    Weber K; Rostert N; Bauersachs S; Wess G
    Mol Cell Biochem; 2015 Apr; 402(1-2):171-80. PubMed ID: 25573325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy.
    Ntelios D; Georgiou E; Alexouda S; Malousi A; Efthimiadis G; Tzimagiorgis G
    Heart Fail Rev; 2022 Jan; 27(1):281-294. PubMed ID: 33656618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers.
    Luo F; Liu W; Bu H
    Heart Fail Rev; 2022 Nov; 27(6):2211-2221. PubMed ID: 35332416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling.
    Zalivina I; Barwari T; Yin X; Langley SR; Barallobre-Barreiro J; Wakimoto H; Zampetaki A; Mayr M; Avkiran M; Eminaga S
    J Mol Cell Cardiol Plus; 2023 Dec; 6():100056. PubMed ID: 38143961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
    J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods.
    Gu J; Zhao Y; Ben Y; Zhang S; Hua L; He S; Liu R; Chen X; Sheng H
    Sci Rep; 2024 Jul; 14(1):17023. PubMed ID: 39043774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of transcriptomic data identifies key hallmark genes in hypertrophic cardiomyopathy.
    Xu J; Liu X; Dai Q
    BMC Cardiovasc Disord; 2021 Jul; 21(1):330. PubMed ID: 34225646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.